Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
2023 Equity Incentive Plan
On
The Compensation Committee of the Board of Directors will administer the 2023 Plan and has the power to determine the size and types of awards granted and may, in its discretion, determine the performance measure(s) to be used for purposes of awards that are to be performance-based. The shares of common stock subject to awards granted under the 2023 Plan that expire, are forfeited because of a failure to vest, or otherwise terminate without being exercised in full will return to the 2023 Plan and be available for issuance under the 2023 Plan.
In the event of a change in control, notwithstanding any vesting schedule with respect to an award of options, SARs, phantom stock units or restricted stock, such option or SAR shall become immediately exercisable with respect to 100 percent of the shares subject to such option or SAR, and the restricted period shall expire immediately with respect to 100 percent of the phantom stock units or shares of restricted stock subject to restrictions. In the event of a change in control, all incomplete award periods in effect on the date the change in control occurs shall end on the date of such change, and the committee shall, (i) determine the extent to which performance goals with respect to each such award period have been met based upon such audited or unaudited financial information then available as it deems relevant, (ii) cause to be paid to each participant partial or full awards with respect to performance goals for each such award period based upon the committee's determination of the degree of attainment of performance goals, and (iii) cause all previously deferred awards to be settled in full as soon as possible.
The Board of Directors or a duly appointed committee thereof may amend or modify the 2023 Plan at any time, subject to any required stockholder approval. To the extent required by applicable law or regulation, and except as otherwise provided in the 2023 Plan, stockholder approval will be required for any amendment that (a) materially increases the number of shares available for issuance under the 2023 Plan, (b) materially expands the class of individuals eligible to receive awards under the 2023 Plan, (c) materially increases the benefits accruing to the participants under the 2023 Plan or materially reduces the price at which shares of common stock may be issued or purchased under the 2023 Plan, (d) materially extends the term of the 2023 Plan, or (e) expands the types of awards available for issuance under the 2023 Plan.
The foregoing description of the terms of the 2023 Equity Incentive Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the 2023 Equity Incentive Plan attached as Exhibit 10.1 to this Current Report on Form 8-K.
1
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Amended and Restated Articles of Incorporation to Increase Authorized Common Stock and Preferred Stock
To enable the Company to meet certain commitments made to stockholders and
convertible note holders, and keep available for issuance additional shares of
its common stock and shares of its 'blank check' preferred stock, the Company's
Board of Directors unanimously approved and adopted a resolution seeking
stockholder approval to authorize the Board of Directors to amend the Amended
and Restated Articles of Incorporation of the Company dated
A copy of the Amended and Restated Articles of Incorporation containing the Authorized Shares Increase Amendment is attached as Exhibit 3.1 to this Current Report on Form 8-K. The above description is qualified by reference to the complete text of the Amended and Restated Articles of Incorporation containing the Authorized Shares Increase Amendment.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On
Pursuant to the Written Consent, the Majority Stockholder approved the following:
? Approval of the Amended and Restated Articles of Incorporation containing the
Authorized Shares Increase Amendment; and
? Approval of the 2023 Equity Compensation Plan
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No Description 3.1 Amended and Restated Articles of Incorporation 10.1 2023 Equity Incentive Plan 104 Cover Page Interactive Data File (formatted as Inline XBRL) 2
© Edgar Online, source